Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4292187
Max Phase: Preclinical
Molecular Formula: C12H19N3O2S
Molecular Weight: 269.37
Molecule Type: Small molecule
Associated Items:
ID: ALA4292187
Max Phase: Preclinical
Molecular Formula: C12H19N3O2S
Molecular Weight: 269.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C2(CCCCC2C)S1
Standard InChI: InChI=1S/C12H19N3O2S/c1-8-6-4-5-7-12(8)15(10(3)17)14-11(18-12)13-9(2)16/h8H,4-7H2,1-3H3,(H,13,14,16)
Standard InChI Key: AKBMCVVTLGXZSU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 269.37 | Molecular Weight (Monoisotopic): 269.1198 | AlogP: 1.90 | #Rotatable Bonds: 0 |
Polar Surface Area: 61.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.69 | CX Basic pKa: | CX LogP: 1.82 | CX LogD: 1.82 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: -0.57 |
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |
Source(1):